← FDA Drug Approvals (Drugs@FDA)

PEMIGATINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2026-06-01

Drug application

FDA Application #

ANDA219552

Application type

Abbreviated New Drug Application (Generic)

Brand name

PEMIGATINIB

Generic name

Pemigatinib

Active ingredients

PEMIGATINIB

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

SANDOZ INC

First approval

2026-06-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown